According to a report by the World Health Organization, close to 1 in 10 people in the world are affected by anxiety and/or depression. Alarmingly, the amount has nearly doubled, from 416 million to 615 million, between 1990 and 2013. Since adequate treatments are still lacking for many patients, the scientists at the Max Planck Institute of Psychiatry hope their research will inform the development of new, more effective treatments.
In a previous study, published in Science in 2011, Jan Deussing’s group revealed for the first time that corticotropin releasing hormone (CRH) signaling in dopaminergic neurons of the ventral tegmental area (VTA) can suppress anxiety.
In their latest study, Deussing’s group has expanded on these findings, providing more mechanistic insights into the “anxiolytic” CRH circuit. Published in the prestigious journal Nature Neuroscience, the scientists describe how the circuit originates in the extended amygdala, in a population of GABAergic neurons that produce CRH.
They traced these neurons and saw that they project down to a region of the midbrain called the VTA, one of the main dopamine-producing areas of the brain. The VTA is known to play a key role in reward and addiction, but here the authors explain how CRH and dopamine interact in anxiety-related behavior.
The CRH-containing projection neurons of the extended amygdala target CRH receptors on dopaminergic VTA neurons. As a result, this circuit can regulate dopaminergic transmission and in turn, emotional behavior.
Lead author of the current study Nina Dedic explains the significance of the findings: “We know that CRH is a major driver of the stress response and that a hyperactive CRH system is implicated in neuropsychiatric pathologies such as mood and anxiety disorders. However, in this study, we could show that CRH does not always act as an aversive, stress-inducing neuropeptide. In fact, specific CRH circuits are required to maintain a positive affective state under normal, stress-free conditions.”
Deussing, research group leader and head of the study explains: “We were surprised to find that a subset of GABAergic CRH neurons in the extended amygdala carry dendritic spines and co-express the postsynaptic density protein, Camk2a. These characteristics are more commonly seen in excitatory, glutamatergic neurons.”
He continues: “Our work suggests that CRH neurons in the extended amygdala are more diverse than we had originally thought. There are locally projecting interneurons as well as spiny, GABAergic, long-range projection neurons.”
In addition to revealing how CRH interacts with dopamine to regulate anxiety, Deussing’s group hopes that these findings will help to unravel the complex stress circuits and networks of the brain.
Anke Schlee | Max-Planck-Institut für Psychiatrie
Switch-in-a-cell electrifies life
18.12.2018 | Rice University
Plant biologists identify mechanism behind transition from insect to wind pollination
18.12.2018 | University of Toronto
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
18.12.2018 | Materials Sciences
18.12.2018 | Physics and Astronomy
18.12.2018 | Physics and Astronomy